Enzalutamide combination with Arsenic trioxide suppresses the progression of castration-resistant prostate cancer

Xiaobing YangDepartment of Urology, Beijing Anzhen Hospital, Capital Medical University, Beijing, ChinaView further author information

Jiahui ZhaoDepartment of Urology, Beijing Anzhen Hospital, Capital Medical University, Beijing, ChinaView further author information

Dechao WeiDepartment of Urology, Beijing Anzhen Hospital, Capital Medical University, Beijing, ChinaView further author information

Tao FengDepartment of Urology, Beijing Anzhen Hospital, Capital Medical University, Beijing, ChinaView further author information

Pengju GuoDepartment of Urology, Beijing Anzhen Hospital, Capital Medical University, Beijing, ChinaView further author information

Qiankun LiDepartment of Urology, Beijing Anzhen Hospital, Capital Medical University, Beijing, ChinaView further author information

Yongxing WangDepartment of Urology, Beijing Anzhen Hospital, Capital Medical University, Beijing, ChinaView further author information

Yili HanDepartment of Urology, Beijing Anzhen Hospital, Capital Medical University, Beijing, ChinaView further author information

Mingchuan LiDepartment of Urology, Beijing Anzhen Hospital, Capital Medical University, Beijing, ChinaView further author information

Yongguang JiangDepartment of Urology, Beijing Anzhen Hospital, Capital Medical University, Beijing, ChinaView further author information

Yong LuoDepartment of Urology, Beijing Anzhen Hospital, Capital Medical University, Beijing, ChinaCorrespondence[email protected]
View further author information

Your download is now in progress and you may close this window